Delivery Order SPE2DB24D2100-SPE2DB24FBAUX
Award Date 4/8/24
Potential Completion Date 4/9/24
Potential Value $15K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a $14,143.79 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml pharmaceuticals. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $11,026.45 contract is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication. This delivery order is part of a larger, single award indefinite delivery contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA Troop Support Medical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication. The award, valued at $11,922.74, has an ultimate completion date of April 12, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a $4,644.32 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication. The award, valued at $24,138.15, has an ultimate completion date of April 9, 2024. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors identified. This delivery order is part of a larger indefinite delivery contract (IDC) awarded...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order (SPE2DB22D1017|SPE2DB24FF4HW) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication. The award has a completion date of March 18, 2024 and a ceiling value of $2,679.83. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which is not part of a set-aside program. This award is associated with a larger...
- The U.S. Defense Logistics Agency (DLA) awarded Delivery Order SPE2DB24FEGB9 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4 mg/3 ml Ozempic 1 mg/dose medication. The firm fixed price delivery order, valued at $4,090.12, has an ultimate completion date of March 21, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, to deliver pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract, SPE2DB22D3004|SPE2DB24FPQ39, to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml medication. The $3,347.93 contract has a performance period through March 12, 2024. AmerisourceBergen Drug Corp, as the prime contractor, holds an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, to provide Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication. The contract has a potential value of $10,811.92 and a completion date of February 16, 2024. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 through December 31, 2025, which serves as the primary vehicle...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $5,158.28 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the provision of Ozempic 1 mg/dose (4 mg/3 ml) 3ml, a prescription medication. The contract has an ultimate completion date of April 17, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with DLA Troop Support Medical, valued at...